EUVIMEDEUVIMED entdecken
Crossref

Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway

Tongbo Zhang, Linxian Zhao, Meng Xu, Peng Jiang, Kai Zhang

International Immunopharmacology · 2024-06 · 134 · 112241

DOI: 10.1016/j.intimp.2024.112241 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Immunopharmacology, 2024-06. Verfasst von Tongbo Zhang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, The Second Hospital of Jilin University, Jilin University, Changchun, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Colitis, Ulcerative, Dextran Sulfate, TOR Serine-Threonine Kinases. Die Arbeit wurde bisher 45-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: Department of Science and Technology of Jilin Province, Jilin Scientific and Technological Development Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis (UC) is a main form of inflammatory bowel disease (IBD), which is a chronic and immune-mediated inflammatory disease. Moringin (MOR) is an isothiocyanate isolated from Moringa oleifera Lam., and has been recognized as a promising potent drug for inflammatory diseases and antibacterial infections. The present study investigated the role of moringin in dextran sulfate sodium (DSS)-induced UC mice. Mouse colitis was induced by adding DSS to the drinking water for seven consecutive days. Our experimental results showed that MOR relieves DSS-induced UC in mice by increasing body weight and colonic length, and reducing the disease activity index and histological injury. Mechanistically, MOR improves intestinal barrier function by increasing the expression of tight junction proteins (TJPs) and enhancing the secretion of mucin in DSS-induced mice. MOR inhibits inflammatory response and intestinal damage by regulating Nrf2/NF-κB signaling pathway and modulating the PI3K/AKT/mTOR pathway. Furthermore, in Nrf2 knockout (Nrf2-/-) mice, the protective effects of MOR on DSS-induced UC were abolished. Meanwhile, treatment with MOR reduced inflammation and cell damage via regulating Nrf2/NF-κB pathway in a lipopolysaccharide (LPS)-induced inflammation model of Caco-2 cells. In contrast, ML385, an Nrf2 inhibitor, might eliminate the protection provided by MOR. Notably, treatment with MOR significantly up-regulated the expression of peroxisome proliferator-activated receptor-γ (PPAR-γ), suggesting that MOR may be a potential PPAR-γ activator. In conclusion, MOR exerts protective effect in UC by improving intestinal barrier function, regulating Nrf2/NF-κB and PI3K/AKT/mTOR signaling pathways, and another effect associated with the regulation of PPAR-γ expression.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Colitis, UlcerativeDextran SulfateTOR Serine-Threonine KinasesNF-kappa BSignal TransductionProto-Oncogene Proteins c-aktMice, Inbred C57BLPhosphatidylinositol 3-KinasesAnimalsHumansMaleMiceCaco-2 CellsAnti-Inflammatory AgentsMice, KnockoutDisease Models, AnimalColon

Stichwörter der Autor:innen

InflammationMoringinNrf2/NF-κBPI3K/AKT/mTORPPAR-γUlcerative colitis

Substanzen

NF-E2-Related Factor 2Dextran SulfateTOR Serine-Threonine KinasesNF-kappa BProto-Oncogene Proteins c-aktNfe2l2 protein, mousePhosphatidylinositol 3-KinasesAnti-Inflammatory AgentsmTOR protein, mouse

Autor:innen und Institutionen

  • Department of General Surgery, The Second Hospital of Jilin University, Jilin University, Changchun, China.
  • State Key Laboratory for Zoonotic Diseases, Key Laboratory for Zoonosis Research of the Ministry of Education, Institute of Zoonosis, and College of Veterinary Medicine, Jilin University, Changchun, China.
  • Department of General Surgery, The Second Hospital of Jilin University, Jilin University, Changchun, China. Electronic address: zhang_kai@jlu.edu.cn.

Förderung

  • Department of Science and Technology of Jilin Province
  • Jilin Scientific and Technological Development Program

Zitieren

APA

Zhang, T., Zhao, L., Xu, M., Jiang, P., & Zhang, K. (2024). Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway. International Immunopharmacology, 134, 112241. https://doi.org/10.1016/j.intimp.2024.112241

Vancouver

Zhang T, Zhao L, Xu M, Jiang P, Zhang K. Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway. International Immunopharmacology. 2024;134:112241. doi:10.1016/j.intimp.2024.112241

BibTeX
@article{Zhang2024,
  author = {Zhang, Tongbo and Zhao, Linxian and Xu, Meng and Jiang, Peng and Zhang, Kai},
  title = {Moringin alleviates DSS-induced ulcerative colitis in mice by regulating Nrf2/NF-κB pathway and PI3K/AKT/mTOR pathway},
  journal = {International Immunopharmacology},
  year = {2024},
  volume = {134},
  pages = {112241},
  doi = {10.1016/j.intimp.2024.112241}
}
Kostenlos starten →